TORONTO - NeuPath Health Inc. (TSXV:NPTH), a leading provider of chronic pain treatment through its network of clinics, has announced its financial results for the first quarter of 2025, ending March 31 [1][2][3][4][5].

The company reported a record total revenue of $19.3 million, marking an 11% increase compared to the same period last year [2][3][4]. This growth was primarily attributed to strong organic expansion in Alberta and Ontario [1].

NeuPath's Chief Executive Officer, Joe Walewicz, commented on the results: 'Strong organic growth in Alberta and Ontario, combined with careful attention to our operations and our clinic footprint, continues to deliver improved operating results' [1][5].

The company also reported positive cash flows, with Adjusted EBITDA reaching $1.3 million, a 49% year-over-year increase. This marks the 25th consecutive quarter of positive Adjusted EBITDA for NeuPath [2][3][4].

In addition to financial growth, NeuPath has made strategic moves to support its expansion. The company secured new credit facilities to drive growth and refinance existing debt [2][3][4]. Furthermore, on May 1, Stephen Lemieux assumed the role of President to lead the implementation of NeuPath's strategic initiatives [2][3][4].

Looking ahead, Walewicz expressed optimism about the company's future: 'We expect continued growth and improved results in 2025, as we continue to evaluate multiple inorganic growth opportunities to better serve patients, with more services, in more communities' [1][5].

NeuPath Health Inc. operates a network of clinics specializing in category-leading chronic pain treatment across Canada. The company's focus on organic growth and strategic expansion aims to enhance its ability to serve more patients in diverse communities [1][5].